#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    CDKL5 deficiency disorder Transient ischaemic attack Myelodysplastic syndrome Bladder cancer Metastatic gastric cancer Liver abscess Mantle cell lymphoma stage II Mantle cell lymphoma Transitional cell cancer of the renal pelvis and ureter Plasma cell myeloma refractory Oesophageal achalasia Cerebral arteriovenous malformation haemorrhagic Hypomagnesaemia Dermatitis Neuroendocrine carcinoma metastatic More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II MELAS syndrome – Life with Disease Haemophilia B without inhibitors – Life with Disease Alexander disease – Diagnostics Brain stem glioma – Basic Information Hereditary optic atrophy – Trials in Disease Mantle cell lymphoma stage IV – Diagnostics Glomerulonephritis rapidly progressive Methylmalonic acidaemia – Trials in Disease Toxic epidermal necrolysis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Io103 Acetate Triptorelin Iobitridol PICLIDENOSON Cloxacillin Ibuprofen Arginine Axatilimab GOVORESTAT Molgramostim Tobramycin Albiglutide Colestyramine GSKVX000000070965 Adalimumab Letrozole Mps-213 Crisantaspase Asfotase Alfa Stx-241 AP31969 SULFATE More therapies…

    Learn about Your Condition

    Acoustic neuroma Transient ischaemic attack Pulmonary tuberculosis Cardiac failure Coma Carpal tunnel syndrome Bronchiolitis Lymphocytic leukaemia Organ donor Deafness neurosensory Peptostreptococcus infection Nasopharyngeal cancer Mumps Bone sarcoma Liver disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Losartan Potassium in Patients with Mild to Moderate Aortic Stenosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Aortic stenosis
    Investigated Drugs:
    • Losartan Potassium
    • Placebo
    Denmark

  • Study on [68Ga]Ga-FAPI-46 and Fludeoxyglucose (18F) PET/CT Imaging for Evaluating Treatment Response in Patients with Advanced Malignant Melanoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Denmark

  • Study of Pembrolizumab and Lenvatinib for Patients with Advanced Vulvar Cancer Not Suitable for Surgery or Radiotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Vulval cancer
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    Germany

  • Study Comparing Serratus Plane Block, Capsaicin, and Botulinum Toxin Type A for Chronic Pain in Post-Mastectomy Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuralgia
    • Post breast therapy pain syndrome
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • MORPHINE
    • Naloxone Hydrochloride
    France

  • Study on Botulinum Toxin Type A for Preventing Shoulder Deformity in Infants with Brachial Plexus Palsy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Sodium Chloride
    France

  • Study on the Long-Term Safety of Belimumab for Adults with Systemic Sclerosis-Related Lung Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Belimumab
    Belgium Denmark Finland France Germany Greece +2
Previous Page
1 … 276 277 278 279 280 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!